Search Within

Hikmat Al-Ahmadie

  1. "Nursing"
Formats
  1. Meeting Abstract (7)
  2. Journal Article (3)
  3. Editorial (1)
Groups
  1. Department of Medicine (11)
  2. Department of Pathology and Laboratory Medicine (11)
  3. Genitourinary Oncology Service (11)
  4. Nursing (11)
  5. Solid Tumor Oncology Division (11)
  6. GSK Faculty (6)

More Groups

People
  1. David Solit (6)
  2. Dean Bajorin (6)
  3. Samuel Funt (5)
  4. Alisa Trout (4)
  5. Annemarie Flaherty (4)
  6. Ashley Regazzi (4)

More People

Years
  1. 2025 (1)
  2. 2023 (4)
  3. 2022 (1)
  4. 2019 (1)
  5. 2013 (1)
  6. 2011 (2)

More Years

Publications
  1. Journal of Clinical Oncology (6)
  2. European Urology (2)
  3. BJU International (1)
  4. Cancer Epidemiology Biomarkers and Prevention (1)
  5. Clinical Cancer Research (1)
Publishers
  1. American Society of Clinical Oncology (6)
  2. American Association for Cancer Research (2)
  3. Elsevier Science, Inc. (2)
  4. Wiley Blackwell (1)

Results (11)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Global-scale patient-partnered genomic databanking: unlocking therapeutic and biological insights in rare cancers through decentralized recruitment and open data sharing
    Meeting Abstract

    Doe-Tetteh, S. A.; Camp, S. Y.; Crowdis, J.; Noronha, A. M.; Alano, T.; Reales, D.; Viale, A.; Donoghue, M.; Socci, N. D.; Berger, M. F.; more...
    Cancer Epidemiology Biomarkers and Prevention (2025)

    Fulltext@MSK | Save
  • An in-progress phase 2 window of opportunity (WOO) trial of targeted therapy with erdafitinib for patients with recurrent FGFR3-altered non–muscle-invasive bladder cancer (NMIBC)
    Meeting Abstract

    Dsouza, N.; Gaffney, C.; Hernandez, C.; Moran, P.; Worth, K.; McCarter, M.; de Jesus, M. R.; Solit, D. B.; Sarungbam, J.; Al-Ahmadie, H. A.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A single-arm, phase II study of durvalumab (D) and tremelimumab (T) for relapsed/refractory germ cell tumors (GCT)
    Meeting Abstract

    Funt, S. A.; Knezevic, A.; Freeman, B. A.; Bolos, M.; Martorana, V.; Donoghue, M.; Khan, S.; Singh, H.; Bromberg, M.; Quinlan, C.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Overcoming barriers to tumor genomic profiling through direct-to-patient outreach
    Journal Article

    Doe-Tetteh, S. A.; Camp, S. Y.; Reales, D.; Crowdis, J.; Noronha, A. M.; Wolff, B.; Alano, T.; Galle, J.; Selcuklu, S. D.; Viale, A.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • A phase II trial of intravesical chemoimmunotherapy with gemcitabine and bacillus Calmette-Guérin (BCG) for patients with BCG-exposed, high-grade, non-muscle–invasive bladder cancer
    Meeting Abstract

    Gaffney, C.; Dsouza, N.; Hernandez, C.; McCarter, M.; Moran, P.; Stasi, K.; Worth, K.; Dalbagni, G.; Donahue, T. F.; Donat, S. M.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Overcoming barriers to tumor genomic profiling through direct patient social media outreach
    Meeting Abstract

    Doe-Tetteh, S. A.; Camp, S. Y.; Crowdis, J.; Noronha, A. M.; Reales, D.; Alano, T.; Viale, A.; Donoghue, M.; Socci, N. D.; Berger, M. F.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Genomic differences between “primary” and “secondary” muscle-invasive bladder cancer as a basis for disparate outcomes to cisplatin-based neoadjuvant chemotherapy
    Editorial

    Pietzak, E. J.; Zabor, E. C.; Bagrodia, A.; Armenia, J.; Hu, W.; Zehir, A.; Funt, S.; Audenet, F.; Barron, D.; Maamouri, N.; more...
    European Urology (2019)

    Fulltext@MSK | Save
  • Phase II study of everolimus in metastatic urothelial cancer
    Journal Article

    Milowsky, M. I.; Iyer, G.; Regazzi, A. M.; Al-Ahmadie, H.; Gerst, S. R.; Ostrovnaya, I.; Gellert, L. L.; Kaplan, R.; Garcia-Grossman, I. R.; Pendse, D.; more...
    BJU International (2013)

    Fulltext@MSK | Save
  • Final results of a phase II study of everolimus (RAD001) in metastatic transitional cell carcinoma (TCC) of the urothelium
    Meeting Abstract

    Milowsky, M. I.; Regazzi, A. M.; Garcia-Grossman, I. R.; Trout, A.; Flaherty, A.; Gerst, S.; Al-Ahmadie, H.; Ostrovnaya, I.; Bajorin, D. F.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Sunitinib in urothelial cancer: Clinical, pharmacokinetic, and immunohistochemical study of predictors of response
    Journal Article

    Gallagher, D. J.; Al-Ahmadie, H.; Ostrovnaya, I.; Gerst, S. R.; Regazzi, A.; Garcia Grossman, I.; Riches, J.; Gounder, S. K.; Flaherty, A. M.; Trout, A.; more...
    European Urology (2011)

    Fulltext@MSK | Save